The findings of these in vivo studies suggest that while the interaction between OPG and the bone microenvironment can lead to an inhibition of bone tumor growth, OPG can promote breast tumor formation and growth at other sites. The gene discussed is TNFRSF11B; the disease is breast neoplasm.